Novartis signs agreement to buy Avidity Biosciences for $12bn
Novartis Acquires Avidity Biosciences for $12bn Novartis has signed an agreement to acquire all outstanding shares of US-based Avidity Biosciences for $12bn in cash. The acquisition…
Novartis Acquires Avidity Biosciences for $12bn Novartis has signed an agreement to acquire all outstanding shares of US-based Avidity Biosciences for $12bn in cash. The acquisition…
IncludEd Conference: Get Inclusion Ready This January, IncludEd is hosting a conference dedicated to Whole-School Inclusion, featuring pra…
FIFA ASEAN Cup Announced for Southeast Asia The tournament was announced during the 47th ASEAN Summit in Kuala Lumpur. FIFA and ASEAN have…
Cullinan Therapeutics Presents Preclinical Data for CLN-978 Cullinan Therapeutics, Inc. (Nasdaq: CGEM) will present new preclinical data f…
Kyverna Therapeutics, Inc. Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigato…
College Vidya Celebrates Online Education Day College Vidya observed October 25th as Online Education Day, honoring learners, educators, a…
Biogen Inc.: Health Canada Grants Authorization for LEQEMBI Biogen Inc. and Eisai Co., Ltd. announced that Health Canada has issued a Noti…
Dolly Dimpley (Smiling Friends) Dolly Dimpley refers to an OC character on the YouTube channel Critter Clipz 2002, who is inserted into cl…
Gauhati High Court Extends Interim Protection for Journalist Abhisar Sharma The Gauhati High Court has extended interim protection for jou…
Early Diagnosis of Head and Neck Squamous Cell Carcinoma Head and neck squamous cell carcinoma (HNSCC) is a diverse group of cancers origi…
Mid-Engined Yaris Makes Belated Super Taikyu Debut The Toyota GR Yaris M Concept made its delayed race debut at the Okayama International …